pwc glp 1 Pill-based GLP-1 medicines set to further reshape consumer spending The Era of the GLP-1

Hemodynamic changes associated with GLP-1 therapy may also contribute to heart rate elevation

Conversely, treatment with exenatide LAR was associated with improved FMD and carotid intima-media thickness, alongside metabolic benefits, in patients with type 2 diabetes (64)

It has been granted GRAS (Generally Recognized as Safe) status by the FDA for use as a food supplement ingredient, though this is distinct from drug approval

J Clin Endocrinol Metab 1964;24:10761082 [DOI] [PubMed] [Google Scholar] 4.Drucker DJ, Nauck MA

After matching, patients who were not on GLP-1Ra were twice as likely to develop end-stage renal disease or dialysis dependence in 5 years after diagnosis compared to patients using GLP-1 agonists (OR 2.35, 95% CI 1.39,3.976)

They are not the most expensive